Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy
Genetics
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy

12, Feb 2026

2
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy
Genetics
Polygenic Risk Scores and Lifetime Multiple Sclerosis Risk: Translating Genetic Susceptibility Into Absolute Probability

12, Feb 2026

3
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program
Genetics
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program

11, Feb 2026

4
Rare Coding Variants Illuminate New Immune Pathways in Multiple Sclerosis: What Exome-Scale Genetics Adds Beyond GWAS
Genetics
Rare Coding Variants Illuminate New Immune Pathways in Multiple Sclerosis: What Exome-Scale Genetics Adds Beyond GWAS

10, Feb 2026

5
Oligodendroglia as Active Mediators of Genetic Risk in Multiple Sclerosis
Genetics
Oligodendroglia as Active Mediators of Genetic Risk in Multiple Sclerosis

09, Feb 2026

Categories:
Genetics
NINJ2 Regulatory Variation and Gene Expression as Predictors of Interferon-β Response in Relapsing–Remitting Multiple Sclerosis
Genetics
NINJ2 Regulatory Variation and Gene Expression as Predictors of Interferon-β Response in Relapsing–Remitting Multiple Sclerosis

04, Jan 2026

IL2RA Variants and Multiple Sclerosis Susceptibility
Genetics
IL2RA Variants and Multiple Sclerosis Susceptibility

05, Jan 2026

Low-Frequency Coding Variants in Multiple Sclerosis: Quantifying Rare Genetic Risk and Refining Immune Mechanisms
Genetics
Low-Frequency Coding Variants in Multiple Sclerosis: Quantifying Rare Genetic Risk and Refining Immune Mechanisms

06, Jan 2026

From Risk to Outcome: Longitudinal Genomics and the Biology of Multiple Sclerosis Severity
Genetics
From Risk to Outcome: Longitudinal Genomics and the Biology of Multiple Sclerosis Severity

06, Jan 2026